Macis et al. analyzed that in addition to enhancing the chemotherapy efficacy of breast cancer xenograft, the high expression of adiponectin was intensively related to the better overall survival (OS) in breast cancer patients with combined chemotherapy [70]. Here, ADIPOQ is linked to breast carcinoma.